DESIGNED TO DELIVER A FUNCTIONAL CURE

Delivering transformative, one-time 
treatments for patients and families 
impacted by rare disease

Our gene addition approach is designed to address disease at the genetic level, delivering one-time treatments with the potential for durable, long-term benefit.

Genetic Medicine Is Here

Our gene addition technology targets the underlying cause of disease with a single dose

Pipeline

Explore the clinical programs
supporting our approved therapies

Sickle Cell Disease

Learn how we’re changing what’s possible for people living with sickle cell disease

Beta-thalassemia

See how we reduce the burden of lifelong transfusions

CALD

Learn about treatment for early, active cerebral adrenoleukodystrophy